CBMP Review

Reason For Treatment The primary condition being treated is chronic neuropathic pain. The last review was on 1 November 2024. The patient's response to the treatment so far has been moderate improvement in pain levels and functional ability, although some breakthrough pain persists. Health Status Update The patient reports no new health conditions or medications. The patient reports mild dry mouth, which they attribute to the current treatment, but no other side effects from the treatment. The patient's general physical and mental health status is as follows: General Health Concerns: The patient mentioned occasional headaches, but these are not new or worsening. Mood And Well-Being: The patient reports an improved mood compared to the previous visit, feeling more hopeful and less anxious about their pain management. Sleep: The patient describes improved sleep patterns, now achieving 6-7 hours of uninterrupted sleep most nights. Self-Harm Or Suicidal Thoughts: The patient denies any self-harm or suicidal thoughts. Social And Lifestyle Context The patient's current living situation is stable, residing with their partner in a detached house. Their support system consists of their partner and a close friend who assists with errands. The patient reports no major life events since the last review. Patient Feedback The patient expressed a good level of satisfaction with their treatment, noting the positive impact on their daily life. Their goals for the next visit include discussing strategies for managing occasional pain flare-ups and exploring options for increasing their physical activity levels. Plan The plan is to continue CBMP therapy. The dosage of the current CBMP medication will remain unchanged. The following advice was provided to the patient: continue with prescribed exercises, monitor pain levels, and record any significant changes or new side effects. Prescription: Medical Cannabis 10mg/ml oil, 0.5ml twice daily, 30ml bottle, 30 days duration.